| RS1567847972 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848100 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567848129 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848147 |
NF1
|
Health Risk |
Pathogenic |
Optic nerve glioma, Optic nerve glioma |
| RS1567848178 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848213 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567848704 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567848711 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567848731 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848739 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848755 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848761 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Neurofibromatosis |
| RS1567848878 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567848976 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567849184 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567849199 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567849208 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567849237 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567849596 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567849826 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567849864 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567849891 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567850647 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1567850984 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567850987 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567851029 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567851054 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567851231 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567851416 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567851445 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567851470 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567851501 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1567851532 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567852567 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567852753 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567852849 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567853044 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1567855081 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567855132 |
FKBP10
|
Health Risk |
Pathogenic/Likely pathogenic |
Osteogenesis imperfecta type 11, Bruck syndrome 1 |
| RS1567855669 |
CHD3
|
Health Risk |
Pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567855704 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567856045 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567856056 |
FKBP10
|
Health Risk |
Pathogenic/Likely pathogenic |
Bruck syndrome 1, Osteogenesis imperfecta type 11 |
| RS1567856331 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567858266 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS1567858306 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567858318 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567858344 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567860075 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567860112 |
CHD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Snijders Blok-Campeau syndrome, Intellectual disability |
| RS1567860640 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Intellectual disability |
| RS1567860891 |
CHD3
|
Health Risk |
Pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567860919 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567861468 |
CHD3
|
Health Risk |
Pathogenic |
Snijders Blok-Campeau syndrome, Intellectual disability |
| RS1567861489 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567861501 |
CHD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567861571 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567861894 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567861977 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567862044 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1567862071 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567862095 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567862283 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS1567862349 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, familial spinal |
| RS1567862353 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS1567862860 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567862956 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567862991 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567863004 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567863580 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567863614 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567863648 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567863732 |
CHD3
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567864750 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |
| RS1567864804 |
TCAP
|
Health Risk |
Likely pathogenic |
Primary familial hypertrophic cardiomyopathy, Primary familial hypertrophic cardiomyopathy |
| RS1567864972 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567864983 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567865010 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567865042 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1567865056 |
NF1
|
Health Risk |
Pathogenic |
— |
| RS1567865089 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS1567865110 |
TCAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy 25 |
| RS1567866856 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1567868429 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1567868477 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1567868598 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1567868785 |
BRIP1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1567870541 |
TLK2
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, autosomal dominant 57 |
| RS1567870911 |
PGAP3
|
Health Risk |
Pathogenic |
— |
| RS1567871600 |
ATP6V0A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, 6 conditions |
| RS1567871748 |
PGAP3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 4, Hyperphosphatasia with intellectual disability syndrome 4 |
| RS1567872320 |
CARD14
|
Health Risk |
Pathogenic |
Papulosquamous eruptions, Papulosquamous eruptions |
| RS1567874485 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1567874779 |
BRIP1
|
Health Risk |
Pathogenic |
— |
| RS1567875399 |
DNAI2
|
Health Risk |
Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1567875446 |
RNF43
|
Health Risk |
Conflicting classifications of pathogenicity |
Sessile serrated polyposis cancer syndrome, Sessile serrated polyposis cancer syndrome |
| RS1567876609 |
DNAI2
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 9 |
| RS1567876917 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS1567876984 |
ACOX1
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitchell syndrome, ACOX1-related disorder |
| RS1567877108 |
CHD3
|
Health Risk |
Likely pathogenic |
Intellectual disability, Snijders Blok-Campeau syndrome |